Phase I trial of recombinant platelet factor 4 (rPF4) in patients with advanced colorectal carcinoma

Investigational New Drugs

Volumn 14, Issue 4, 1996, Pages 387-389

  Belman, Neil ^a   Bonnem, Eric M ^b   Harvey, Harold A ^a   Lipton, Allan ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b REPLIGEN CORPORATION   (United States)

Author keywords

Angiogenesis inhibitor; Colorectal carcinoma; Platelet factor 4 (rPF4)

Indexed keywords

FIBRINOGEN; FLUOROURACIL; RECOMBINANT THROMBOCYTE FACTOR 4;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; DEEP VEIN THROMBOSIS; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; METASTASIS; MUSCLE TWITCH; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL;

EID: 0030482306     PISSN: 01676997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00180815     Document Type: Article

References (12)

1. Willett CG, Tepper JE, Cohen AM et al.: Failure patterns following curative resection of colon carcinoma. Ann Surg 200:685-690, 1984
2. Willett CG, Tepper JE, Cohen AM et al.: Local failure following curative resection of colonic adenocarcinoma. Int J Radiat Oncol Biol Phy 10:645-651, 1984
3. Eisenberg B, DeCrosse JJ, Harford F et al.: Carcinoma of the colon and rectum: natural history. N Engl J Med 266:211-219, 1962
4. Panettiere FJ, Chen TT: The SWOG large bowel study. Proc Am Soc Clin One 4:76, 1985
5. Grage TB, Moss SE: Adjuvant chemotherapy in cancer of the colon and rectum: demonstration of effectiveness of prolonged 5FU chemotherapy. Surg Clin N America 61:1321-1329, 1981
6. Laurie J, Moertel C, Hemming T et al.: Surgical adjuvant therapy of poor prognosis colorectal cancer with levamisole alone or in combination with 5FU: a North Central Oncology Group study. Proc Am Soc Clin One 5:81, 1986
7. Data on file: Repligen Corporation
8. Maione TE, Gray GS, Petro J et al.: Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 237:77-79, 1990
9. Sharpe RJ, Randolph HR, Scott CF et al.: Growth inhibition of murine melanoma and human colon carcinoma by recombinant human platelet factor 4. J Natl Cancer Inst 82:848-853, 1990
10. Broxmeyer HE, Sherry B, Cooper S et al.: Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression. J Immunol 150:3348-3458, 1993
11. Kuna P, Reddigari SR, Rucinski D et al.: Inhibition of MCAF/MCP-1-induced histamine release from human basophils by RANTES. MIP-1a, MIP-1b, PF4, CTAP-III, IL-8 & IP-10 (abstr). J Allergy Clin Immunol 91:314, 1993
12. Zucker MB, Katz IR: Platelet factor 4: production, structure and physiologic and immunologic action. Proc Soc Exp Biol Med 198:693-702, 1991